3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
8
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Basal Cell
3
Warts
1
Tongue Neoplasms
1
Sezary Syndrome
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Mycosis Fungoides
1
Mouth Neoplasms
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoid Interstitial Pneumonia
1
Leukoplakia, Oral
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Bowen's Disease
1
Basal Cell Nevus Syndrome
1
Barrett Esophagus
1
Interventions
Cisplatin
7
Cetuximab
6
Radiotherapy, Intensity-Modulated
4
pembrolizumab
3
durvalumab
3
Radiotherapy
2
Radiation
2
Observation
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
trametinib
1
sodium thiosulfate
1
gluconic acid
1
ficlatuzumab
1
Zinc
1
Watchful Waiting
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Tadalafil
1
Sirolimus
1
RRx-001
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Photochemotherapy
1
Periodontal Debridement
1
Oral Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Mouth Neoplasms
×
Photochemotherapy
×
Clear all
NCT03638622
2021-02-21
UH3-India
Massachusetts General Hospital
Phase 1/2
Completed
30 enrolled
4 charts